The Evaluation of the Effect of Microfluidic Sperm Sorting Chip

Status Completed

Clinical Trial Summary

Microfluidic chips are one of the methods of sperm separation to eliminate DNA fragmentation in sperm. It is thought that the separation of sperm by centrifugation in the classical gradient density (Percoll) method used in sperm separation in IVF (in vitro fertilization) laboratories leads to the increase of reactive oxygen radicals in sperm and this leads to sperm DNA fragmentation. Studies comparing Percoll and microfluidic chip method in terms of sperm, embryo quality and pregnancy rates are limited. In this context, it is aimed to investigate the effect of Percoll or Microfluidic Chip Technology on the quality of sperms and embryos obtained with these sperms and their pregnancy rates prospectively.

Clinical Trial Description

The increase in male infertility rate due to environmental and physiological conditions leads to an increase in the use of assisted reproductive techniques. Isolation of living and morphologically normal live sperm is an integrated procedure in commonly used IVF / ICSI(intracytoplasmic sperm injection) / IUI(intrauterine insemination) procedures. Although current IVF / ICSI procedures result in a successful pregnancy of around 50%, the process can be greatly compromised if the selected sperm is abnormal. Microfluidic chips are one of the recommended sperm separation methods to eliminate DNA fragmentation in sperm. It is thought that the separation of the sperm by centrifugation in the classical gradient density (Percoll) method which is used in the separation of sperm in the IVF Laboratories, causes the increase of reactive oxygen radicals in sperm and this leads to sperm DNA fragmentation. Studies comparing Percoll and microfluidic chip method in terms of sperm, embryo quality and pregnancy rates are limited. In this context, it is aimed to investigate the effect of Percoll or Microfluidic Chip Technology on the quality of sperms and embryos obtained with these sperms and their pregnancy rates prospectively. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03960229
Study type	Interventional
Source	Bezmialem Vakif University
Contact
Status	Completed
Phase	N/A
Start date	May 23, 2019
Completion date	September 23, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05503862` - Home Semen Testing in Men Beginning Attempts to Conceive	N/A
Recruiting	`NCT03307655` - Relationship Between Nitric Oxide (NO) in Follicular Fluid and Sperm Fertilization Ability	N/A
Withdrawn	`NCT02839447` - A Clinical Evaluation of Semen Quality Using the MiOXSYS™ System 2.0
Completed	`NCT00975117` - Spermotrend in the Treatment of Male Infertility	Phase 3
Completed	`NCT00756561` - HOP-2A - Intratesticular Hormone Levels	N/A
Recruiting	`NCT04541459` - Validation of New Devices Against Ambient Electromagnetic Radiation	Early Phase 1
Completed	`NCT02889341` - Valuation of Variable Dose of Docosahexanoic Acid for the Improvement of the Parameters of Male Fertility	N/A
Not yet recruiting	`NCT03167008` - Vitamin D Level vs Semen Parameters
Completed	`NCT02268123` - Correlating In Vitro Fertilization Outcomes After Euploid Blastocyst Transfer With Sperm DNA Fragmentation
Completed	`NCT01232465` - Impact of Sperm DNA Integrity on In Vitro Cycles	N/A
Recruiting	`NCT00119925` - 'SPRING'-Study: "Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists"	N/A
Completed	`NCT03552081` - Tobacco and Sperm Genome: Effects of Smoking Cessation	N/A
Recruiting	`NCT05200663` - Efficacy Comparison of Tamoxifen and Tamoxifen With Antioxidants on Semen Quality of Male With Idiopathic Infertility	Phase 2
Completed	`NCT02025270` - MSCs For Treatment of Azoospermic Patients	Phase 1/Phase 2
Recruiting	`NCT06147700` - Identifying Molecular Determinants of Infertility in Men (MODIFY)
Recruiting	`NCT06188936` - Home Semen Analysis Tests as a Screening Tool for Fertility Patients	N/A
Recruiting	`NCT04200118` - Epigenetic and Genetic Effects in Cancer Patients: Analysis Pre and After Treatment
Terminated	`NCT02605070` - Pilot Study on the Effects of FSH Treatment on the Epigenetic Characteristics of Spermatozoa in Infertile Patients With Severe Oligozoospermia	Phase 3
Completed	`NCT01407432` - Impact of Folates in the Care of the Male Infertility	Phase 3
Completed	`NCT00596739` - A Study of the Pre- and Post-operative Semen Analyses and Reproductive Hormone Levels of Men Undergoing Weight-reduction Surgery	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Evaluation of the Effect of Microfluidic Sperm Sorting Chip 'Labs-on-a-chip' on IVF Success in Male Factor

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms